Who is sponsoring NCT03324516?

NCT03324516 is sponsored by Johns Hopkins University.

What drugs are being tested in NCT03324516?

Interventions in NCT03324516: Re-Suspension of the temporal muscle after a craniotomy., Traditional re-suspension of the temporal muscle.

What condition does NCT03324516 study?

NCT03324516 studies Temporal Wasting.

Is NCT03324516 still recruiting?

NCT03324516 is currently withdrawn. Last updated 23 July 2020.

Last reviewed 2020-07-23 · How we verify

NCT03324516: TMS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Temporal Muscle Suspension of Temporal Hollowing

Withdrawn NA Last updated 23 July 2020

What this trial tests

NA trial testing Re-Suspension of the temporal muscle after a craniotomy. in Temporal Wasting. Withdrawn.

Timeline

1 July 2020

Primary endpoint
1 January 2021

1 January 2021

Quick facts

Lead sponsor	Johns Hopkins University
Phase	NA
Status	Withdrawn
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Start date	1 July 2020
Primary completion	1 January 2021
Estimated completion	1 January 2021
Sites	1 location across United States

Drugs / interventions tested

Re-Suspension of the temporal muscle after a craniotomy.
Traditional re-suspension of the temporal muscle

Conditions studied

Temporal Wasting — all drugs for Temporal Wasting →

Sponsor

Johns Hopkins University

Who can join

18 and older, any sex, with Temporal Wasting. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective is to identify which patients undergoing a traditional pterional approach with 2 different surgical techniques for TMS (Temporal Muscle Suspension) will develop TH (Temporal Hollowing. Pre and post-operative CT scans will be reviewed and analysis with previously proven metrics will be performed.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Johns Hopkins University trials

Trials by the same sponsor.

NCT06236542 — Tracheostomy Robotics and Cutting-edge Health Education for Airway Safety · NA · not yet recruiting
NCT07532252 — Daridorexant for Alcohol Use Disorder · Phase 2 · not yet recruiting
NCT06687655 — Impact of Exogenous Ketones on Sleep Apnea · Phase 1, PHASE2 · not yet recruiting
NCT07079111 — 3D Printed Occlusal Splints for Intraoperative Use · NA · not yet recruiting
NCT02998502 — The Use of a FDA Cleared, Drug-free, Breathing System for Anxiety and Panic Disorders in Children and Teens · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03324516 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Johns Hopkins University
Last refreshed: 23 July 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03324516.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing